• The BDA has Issued Marketing Authorization for the Drug Dexketoprofen-Tchaikapharma

    October 22, 2015

    Tchaikapharma High Quality Medicines Inc. has received marketing authorization for the medicinal product Dexketoprofen-Tchaikapharma of 50 mg / 2 ml solution for injection or concentrate for solution for infusion.
    The product is a pain relieving medicine from the group of the so called Nonsteroidal anti-inflammatory drugs (NSAIDs). It is used for the treatment of acute, moderate to severe pain when taking pills is not appropriate, e.g. for post-operative pain, renal colic (severe pain in the kidney area), back pain.
    The active substance in an ampoule with dexketoprofen trometamol (73,80 mg), corresponding to dexketoprofen (INN) 50 mg.
    Prescription-only drug
    ATC code: M01AE17